Case report: verapamil-induced subacute cutaneous lupus erythematosus.

Boaz Kurtis; Matthew J. Larson; Mai P. Hoang; Jack B. Cohen

Case report: verapamil-induced subacute cutaneous lupus erythematosus.

Boaz Kurtis, Matthew J. Larson, Mai P. Hoang, Jack B. Cohen

Research output: Contribution to journal › Article › peer-review

Abstract

Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.

Original language	English (US)
Pages (from-to)	506-508
Number of pages	3
Journal	Journal of drugs in dermatology : JDD
Volume	4
Issue number	4
State	Published - 2005

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{22dc4cf59eac41709c39d9d5f159d03e,

title = "Case report: verapamil-induced subacute cutaneous lupus erythematosus.",

abstract = "Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",

author = "Boaz Kurtis and Larson, {Matthew J.} and Hoang, {Mai P.} and Cohen, {Jack B.}",

year = "2005",

language = "English (US)",

volume = "4",

pages = "506--508",

journal = "Journal of drugs in dermatology : JDD",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "4",

}

TY - JOUR

T1 - Case report

T2 - verapamil-induced subacute cutaneous lupus erythematosus.

AU - Kurtis, Boaz

AU - Larson, Matthew J.

AU - Hoang, Mai P.

AU - Cohen, Jack B.

PY - 2005

Y1 - 2005

N2 - Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.

AB - Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.

UR - http://www.scopus.com/inward/record.url?scp=33644690867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644690867&partnerID=8YFLogxK

M3 - Article

C2 - 16004027

AN - SCOPUS:33644690867

SN - 1545-9616

VL - 4

SP - 506

EP - 508

JO - Journal of drugs in dermatology : JDD

JF - Journal of drugs in dermatology : JDD

IS - 4

ER -

Case report: verapamil-induced subacute cutaneous lupus erythematosus.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this